Skip to main content
Year archive

PRESCIENT THERAPEUTICS LIMITED — 2025 filings

All 66 regulatory filings released by PRESCIENT THERAPEUTICS LIMITED (PTX) in 2025, sourced directly from the official regulator.

66 Filings
2025 Period
2025 filings (66)
Filing Released Lang
Notification regarding unquoted securities - PTX 6 pages 18.6KB
Share Issue/Capital Change
2025-12-18 English
PTX secures EU Authorisation to commence PTX-100 Trial 2 pages 124.0KB
Capital/Financing Update
2025-12-14 English
Change of Director's Interest Notice 2 pages 225.9KB
Director's Dealing
2025-11-20 English
Change of Director's Interest Notice 2 pages 223.6KB
Director's Dealing
2025-11-20 English
Change of Director's Interest Notice 3 pages 230.0KB
Director's Dealing
2025-11-20 English
Change of Director's Interest Notice 3 pages 228.4KB
Director's Dealing
2025-11-20 English
Change of Director's Interest Notice 3 pages 231.0KB
Director's Dealing
2025-11-20 English
PTX secures EU Orphan Drug Designation for PTX-100 in CTCL 3 pages 128.1KB
Regulatory Filings
2025-11-18 English
Notification regarding unquoted securities - PTX 7 pages 22.5KB
Share Issue/Capital Change
2025-11-17 English
Amended Constitution 73 pages 1.5MB
Governance Information
2025-10-27 English
Chair Address and CEO AGM Presentation 20 pages 1.4MB
AGM Information
2025-10-13 English
Results of Annual General Meeting 3 pages 240.5KB
Declaration of Voting Results & Voting Rights Announcements
2025-10-13 English
September Quarterly Updated and Appendix 4C 10 pages 256.5KB
Interim / Quarterly Report Q1 2026
2025-10-09 English
Notice of Annual General Meeting/Proxy Form 28 pages 1.0MB
AGM Information
2025-09-11 English
Notification regarding unquoted securities - PTX 6 pages 20.7KB
Share Issue/Capital Change
2025-08-31 English
Application for quotation of securities - PTX 6 pages 18.2KB
Capital/Financing Update
2025-08-28 English
Completion of Share Placement & s708A Cleansing Notice 3 pages 161.5KB
Capital/Financing Update
2025-08-28 English
Appendix 4E and 2025 Annual Report 53 pages 1.2MB
Annual Report FY 2025
2025-08-19 English
Appendix 4G and Corporate Governance Statement 26 pages 899.7KB
Regulatory Filings
2025-08-19 English
Application for quotation of securities - PTX 6 pages 18.5KB
Share Issue/Capital Change
2025-08-11 English
Share Placement Progress and Cleansing Notice 3 pages 315.6KB
Capital/Financing Update
2025-08-11 English
Change of Director's Interest Notice 2 pages 136.5KB
Director's Dealing
2025-08-10 English
Change of Director's Interest Notice 3 pages 143.0KB
Director's Dealing
2025-08-10 English
Change of Director's Interest Notice 2 pages 139.6KB
Director's Dealing
2025-08-10 English
Application for quotation of securities - PTX 6 pages 18.1KB
Share Issue/Capital Change
2025-08-04 English
Prescient successfully completes $3 million Placement 4 pages 186.2KB
Capital/Financing Update
2025-07-30 English
Proposed issue of securities - PTX 5 pages 17.7KB
Capital/Financing Update
2025-07-30 English
June 2025 Quarterly Update and Appendix 4C 10 pages 373.8KB
Interim / Quarterly Report Q4 2025
2025-07-29 English
Trading Halt 2 pages 337.3KB
Regulatory Filings
2025-07-28 English
Prescient announces results of SPP & Launches Placement 4 pages 237.9KB
Capital/Financing Update
2025-07-28 English
Prescient Therapeutics - Extension of Share Purchase Plan 4 pages 306.2KB
Capital/Financing Update
2025-07-21 English
PTX Opens First U.S. Site for PTX-100 Phase 2a Trial 3 pages 308.0KB
Regulatory Filings
2025-07-15 English
Prescient Therapeutics Extends Share Purchase Plan 5 pages 129.6KB
Capital/Financing Update
2025-07-14 English
Update - Proposed issue of securities - PTX 6 pages 20.9KB
Capital/Financing Update
2025-07-14 English
Notification of cessation of securities - PTX 4 pages 14.8KB
Share Issue/Capital Change
2025-07-13 English
Notification of cessation of securities - PTX 4 pages 14.8KB
Share Issue/Capital Change
2025-07-07 English
Prescient Share Purchase Plan Investor Presentation 40 pages 1.7MB
Investor Presentation
2025-07-03 English
Share Purchase Plan Cleansing Notice 3 pages 224.0KB
Capital/Financing Update
2025-07-01 English
Prescient Therapeutics Opens Share Purchase Plan 11 pages 401.6KB
Capital/Financing Update
2025-07-01 English
Prescient Therapeutics Launches Share Purchase Plan for $7m 5 pages 165.4KB
Capital/Financing Update
2025-06-30 English
Proposed issue of securities - PTX 6 pages 21.1KB
Capital/Financing Update
2025-06-30 English
Change of Registered Office and Principal Place of Business 3 pages 138.9KB
Regulatory Filings
2025-06-01 English
PTX Updated Investor Presentation 38 pages 1.7MB
Investor Presentation
2025-05-28 English
First Patient dosed for PTX-100 Phase 2a Study 4 pages 207.7KB
Capital/Financing Update
2025-05-26 English
Prescient Therapeutics - Investor Briefing 23 pages 1.4MB
Investor Presentation
2025-05-20 English
Change of Director's Interest Notice 2 pages 310.3KB
Director's Dealing
2025-05-05 English
Change of Director's Interest Notice 3 pages 234.7KB
Director's Dealing
2025-05-01 English
March 2025 Quarterly Update and Appendix 4C 10 pages 499.6KB
Interim / Quarterly Report Q3 2025
2025-04-27 English
Prescient Therapeutics - Investor Briefing 24 pages 1.8MB
Investor Presentation
2025-04-16 English
PTX-100 receives U.S. FDA Fast Track Designation 4 pages 227.5KB
Regulatory Filings
2025-04-15 English
Initial Director's Interest Notice 2 pages 158.7KB
Director's Dealing
2025-04-10 English
PTX appoints Melanie Farris as Non-Executive Director 4 pages 191.0KB
Board/Management Information
2025-04-09 English
Final Director's Interest Notice 2 pages 181.7KB
Director's Dealing
2025-03-31 English
Prescient Therapeutics - Investor Briefing 33 pages 2.5MB
Regulatory Filings
2025-03-30 English
PTX Opens First Clinical site for PTX-100 Phase 2a Study 4 pages 195.8KB
Capital/Financing Update
2025-03-25 English
Change of Chief Medical Officer 4 pages 157.8KB
Board/Management Information
2025-03-23 English
PTX-100 clinical data presented at leading TCL meeting 4 pages 166.8KB
Regulatory Filings
2025-03-20 English
Change of Director's Interest Notice 3 pages 239.5KB
Director's Dealing
2025-03-16 English
Change of Board Chair 3 pages 243.2KB
Board/Management Information
2025-03-10 English
Appendix 4D and Half Year Financial Report 19 pages 850.2KB
Interim / Quarterly Report H1 2025
2025-02-20 English
December 2024 Quarterly Update and Appendix 4C 10 pages 456.6KB
Interim / Quarterly Report Q2 2025
2025-01-30 English
December 2024 Quarterly Update and Appendix 4C - amended 10 pages 479.1KB
Interim / Quarterly Report Q2 2025
2025-01-30 English
OmniCAR technical issues resolved and program to progress 4 pages 584.6KB
Regulatory Filings
2025-01-22 English
Notification regarding unquoted securities - PTX 7 pages 21.6KB
Share Issue/Capital Change
2025-01-21 English
Final Director's Interest Notice 2 pages 173.6KB
Director's Dealing
2025-01-21 English
Notification of cessation of securities - PTX 4 pages 14.8KB
Share Issue/Capital Change
2025-01-12 English